Publication:
Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.

Loading...
Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Besiroglu, Mehmet

Shbair, Abdallah Tm

Yasin, Ayse Irem

Topcu, Atakan

Turk, HACI MEHMET

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source

Keywords

Keywords

Citation

Besiroglu M., Shbair A. T. , Yasin A. I. , Topcu A., Turk H. M. , Demir T., -Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.-, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, cilt.31, ss.39-44, 2021

Endorsement

Review

Supplemented By

Referenced By

4

Views

51

Downloads

View PlumX Details


Sustainable Development Goals